With more than a century of experience in satisfying both fundamental and emerging needs of humans, we at Lonza have a unique capability to connect our biotech expertise with our fine chemical know-how to help our customers meet some of the world’s greatest challenges. These global megatrends include the universal desire for disease prevention and treatment, healthful food, enhanced hygiene, personal well-being and energy conservation.

To satisfy these escalating needs along the entire Healthcare Continuum®, both the Pharma Biotech & Nutrition and Specialty Ingredients segments excel at consistently delivering high-quality products, providing tailored technical and regulatory support, and offering a broad portfolio of registered and approved actives that meet the world's most exacting regulatory standards

Lonza’s businesses are satisfying vital global needs that often span the intersecting effects of four key global megatrends:

  • Growing World Population
  • Aging of Global Populations
  • Rapid Growth of Megacities
  • Growth of Middle Classes in BRIC and VISTA Countries

BRIC countries are Brazil, Russia, India and China. VISTA countries are Vietnam, Indonesia, South Africa, Turkey and Argentina.


Growing World Population

Growing populations, including rising middle classes in emerging countries and megacities, are triggering needs for simple yet effective hygiene products to combat a broad range of pathogens, including key bacteria and viruses that are often present in healthcare facilities. Around the globe our sanitizers and disinfectants are used in hospitals and other medical settings, industrial cleanrooms, homes, restaurants and institutional food-preparation facilities, schools, offices, gyms and cruise ships.

Our nutrition and agro businesses are at the forefront of helping address consumers’ growing needs for safe, healthful and abundant foods and supplements.

Custom-manufactured crop growth and protection products, for example, help our customers optimize yields, often with less water and a reduced need for pesticides. Lonza is a world leader in molluscicides, with proprietary products that protect lettuce, other greens and rice from the damage caused by slugs and snails.


Aging World Populations

The rapid growth in elderly populations is tied to the growing prevalence of cancer, heart disease, diabetes and many other age-related illnesses. Lonza’s Pharma Biotech & Nutrition segment plays a major role in the development of medicines that have the potential to extend and improve the quality of life in aging populations.

The need for effective yet reasonably priced medicines and therapies not only applies to BRIC and VISTA nations, but also to developed nations. Lonza is a leader worldwide in helping customers create novel, yet cost-effective “small-molecule” medicines, as well as the more complex “large-molecule” medicines like biologics.

Also Lonza is an innovative pioneer in the development of the most-advanced, cutting-edge medicines and therapies in the world today, such as gene-based medicines for patients with serious diseases.

Lonza’s nutrition business is addressing the needs of an aging population with the strategy of providing “Active Ingredients for Living Actively.” The focus here is accelerating development of our nutritional portfolio in areas of muscle health, healthy weight maintenance, mobility (e.g. joint health) and healthy immune-system and digestion support.

Lonza’s consumer health businesses are at the forefront of helping people feel and look their best. The rapid growth of elderly populations in the West and in Asian nations such as China and Japan is driving ever-rising demand for healthful foods and nutritional supplements, anti-aging cosmetics and other personal-care products.


Rapid Growth of Megacities

Movement of populations from rural areas to megacities is generating a need for many Lonza products and services, including sustainable building products. Wood is one of the world’s most vital, renewable, natural resources; and engineered wood is an advanced material that provides strength, durability and beauty in buildings.

Lonza's wood businesses offer innovative technologies that, for example, add a preservative and water-repellent property to our customers’ engineered timbers. They also offer cutting-edge products that combine fungicides and insecticides to protect engineered wood from insects and decay.

The threat of fire in densely developed cities helps explain the growing use of our fire-retardant treatments for wood used in schools, apartment complexes, homes, train stations, hospitals and other areas.


Growth of Middle Classes in BRIC and VISTA Countries

The growing middle classes in BRIC and VISTA countries will generate increasing demand for medication. With modern facilities in Singapore and China, our Pharma Biotech & Nutrition segment is capitalizing on rising demand in Asia Pacific and elsewhere for affordable medicines and biotech therapies.

Many of these nations are in hot, humid areas of the planet. This fact underscores the value of our coatings and composites businesses, which help to fight mold and the “sick-building syndrome” in facilities by providing protective biocides and fungicides for paints, wallboard, ceiling tiles, adhesives and other building products.